Medical and Science
Perspectives from one Australian team’s search for a COVID-19 vaccine

Medical News: While it may not be here tomorrow, scientists around the world are racing to develop viable COVID-19 vaccine candidates.
In this podcast episode, two Australian researchers from The University of Queensland share how their team identified a lead vaccine candidate from an initial field of 200 in just over 5 weeks.

Dodi Axelson, Head of Communications, Cytiva, Sweden and Conor McKechnie, Vice President Marketing, Cytiva, United Kingdom share the perspectives of:
- Trent Munro, Professor & Senior Group Leader at the Australian Institute for Bioengineering Nanotechnology and
- Keith Chappell, Associate Professor & Affiliate Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology from The University of Queensland.
Discovery Matters is a collection of stories and insights on matters of discovery that advance science and medicines. Brought to you by the curious people at Cytiva.
Digital & Innovation

Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreNews & Trends - MedTech & Diagnostics

Health Minister and Opposition face off at the National Press Club
In a blistering showdown at the National Press Club, Federal Health Minister, Mark Butler, and his Opposition counterpart Senator Anne […]
MoreNews & Trends - Pharmaceuticals

GSK nabs label expansion for RSV vaccine
Coinciding with World Immunisation Week (24-30 April), GSK has secured TGA approval for its respiratory syncytial virus (RSV) vaccine, marking […]
MoreNews & Trends - MedTech & Diagnostics

Low-value imaging linked to high human cost
Imagining has become a cornerstone of modern medicine, for their ability to detect cancers, guide surgeries, and uncover internal injuries […]
More